Microbot Medical Inc. (MBOT)
MBOT Stock Price Chart
Explore Microbot Medical Inc. interactive price chart. Choose custom timeframes to analyze MBOT price movements and trends.
MBOT Company Profile
Discover essential business fundamentals and corporate details for Microbot Medical Inc. (MBOT) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Medical - Instruments & Supplies
IPO Date
25 Mar 1992
Employees
20.00
Website
https://www.microbotmedical.comCEO
Harel Gadot
Description
Microbot Medical Inc. operates as a pre-clinical stage medical device company, concentrating its efforts on the research, design, and development of robotic instruments for endoluminal surgery, specifically targeting the field of minimally invasive procedures. Leveraging its proprietary micro-robotic technologies, which include ViRob, TipCAT, CardioSert, and Liberty, the company is actively developing several key products. These include a Self-Cleaning Shunt intended for the treatment of hydrocephalus and normal pressure hydrocephalus, as well as a single-use robotic system designed for various endovascular interventional applications. Additionally, Microbot Medical maintains a robust, multi-generational product pipeline. Its global intellectual property portfolio is substantial, encompassing 42 granted or allowed patents and an additional 23 patent applications currently under review. The company also benefits from a strategic collaboration agreement with Stryker Corporation, focusing on joint technology development. Established in 2010, Microbot Medical Inc. is headquartered in Hingham, Massachusetts.
MBOT Financial Timeline
Browse a chronological timeline of Microbot Medical Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 11 Aug 2026
EPS estimate is -$0.08, while revenue estimate is $333.33k.
Earnings released on 13 May 2026
EPS came in at -$0.05 surpassing the estimated -$0.08 by +37.50%, while revenue for the quarter reached $100.00k , missing expectations by -77.78%.
Earnings released on 26 Mar 2026
EPS came in at -$0.04 surpassing the estimated -$0.06 by +33.33%.
Earnings released on 12 Nov 2025
EPS came in at -$0.07 falling short of the estimated -$0.06 by -16.67%.
Earnings released on 12 Aug 2025
EPS came in at -$0.10 falling short of the estimated -$0.08 by -25.00%.
Earnings released on 14 May 2025
EPS came in at -$0.08 surpassing the estimated -$0.13 by +38.46%.
Earnings released on 25 Mar 2025
EPS came in at -$0.20 falling short of the estimated -$0.18 by -11.11%.
Earnings released on 13 Nov 2024
EPS came in at -$0.20 falling short of the estimated -$0.17 by -17.65%.
Earnings released on 14 Aug 2024
EPS came in at -$0.17 matching the estimated -$0.17.
Earnings released on 15 May 2024
EPS came in at -$0.17 matching the estimated -$0.17.
Earnings released on 27 Mar 2024
EPS came in at -$0.26 falling short of the estimated -$0.25 by -4.00%, while revenue for the quarter reached $142.00k .
Earnings released on 14 Nov 2023
EPS came in at -$0.21 surpassing the estimated -$0.25 by +16.00%.
Earnings released on 14 Aug 2023
EPS came in at -$0.25 surpassing the estimated -$0.31 by +19.35%.
Earnings released on 31 Mar 2023
EPS came in at -$0.38 surpassing the estimated -$0.45 by +15.56%.
Earnings released on 29 Mar 2023
EPS came in at -$0.54 falling short of the estimated -$0.47 by -14.89%.
Earnings released on 14 Nov 2022
EPS came in at -$0.49 surpassing the estimated -$0.51 by +3.92%.
Earnings released on 15 Aug 2022
EPS came in at -$0.49 falling short of the estimated -$0.45 by -8.89%.
Earnings released on 16 May 2022
EPS came in at -$0.45 falling short of the estimated -$0.42 by -7.14%.
Earnings released on 31 Mar 2022
EPS came in at -$0.54 matching the estimated -$0.54.
Earnings released on 15 Nov 2021
EPS came in at -$0.36 matching the estimated -$0.36.
Earnings released on 16 Aug 2021
EPS came in at -$0.35 matching the estimated -$0.35.
MBOT Stock Performance
Access detailed MBOT performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.
